Načítá se...

Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling

BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been widely used in the treatment of non-small cell lung cancer (NSCLC) patients with sensitive EGFR mutations. However, the survival of patients with EGFR-TKI administration is limited by the inevitable develop...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Med Sci Monit
Hlavní autoři: Sun, Xiang, Xu, Yang, Wang, Yi, Chen, Qian, Liu, Liu, Bao, Yangyi
Médium: Artigo
Jazyk:Inglês
Vydáno: International Scientific Literature, Inc. 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5978026/
https://ncbi.nlm.nih.gov/pubmed/29763936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.909977
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!